Literature DB >> 32813261

Epitranscriptomics in the Heart: a Focus on m6A.

Jacob Z Longenecker1, Christopher J Gilbert1, Volha A Golubeva1, Colton R Martens1, Federica Accornero2.   

Abstract

PURPOSE OF REVIEW: Post-transcriptional modifications are key regulators of gene expression that allow the cell to respond to environmental stimuli. The most abundant internal mRNA modification is N6-methyladenosine (m6A), which has been shown to be involved in the regulation of RNA splicing, localization, translation, and decay. It has also been implicated in a wide range of diseases, and here, we review recent evidence of m6A's involvement in cardiac pathologies and processes. RECENT
FINDINGS: Studies have primarily relied on gain and loss of function models for the enzymes responsible for adding and removing the m6A modification. Results have revealed a multifaceted role for m6A in the heart's response to myocardial infarction, pressure overload, and ischemia/reperfusion injuries. Genome-wide analyses of mRNAs that are differentially methylated during cardiac stress have highlighted the importance of m6A in regulating the translation of specific categories of transcripts implicated in pathways such as calcium handling, cell growth, autophagy, and adrenergic signaling in cardiomyocytes. Regulation of gene expression by m6A is critical for cardiomyocyte homeostasis and stress responses, suggesting a key role for this modification in cardiac pathophysiology.

Entities:  

Keywords:  Epigenetics; Heart failure; RNA methylation; m6A

Mesh:

Substances:

Year:  2020        PMID: 32813261      PMCID: PMC7486268          DOI: 10.1007/s11897-020-00473-z

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN: 1546-9530


  65 in total

1.  The YTH domain is a novel RNA binding domain.

Authors:  Zhaiyi Zhang; Dominik Theler; Katarzyna H Kaminska; Michael Hiller; Pierre de la Grange; Rainer Pudimat; Ilona Rafalska; Bettina Heinrich; Janusz M Bujnicki; Frédéric H-T Allain; Stefan Stamm
Journal:  J Biol Chem       Date:  2010-02-18       Impact factor: 5.157

2.  Loss of YTHDF2-mediated m6A-dependent mRNA clearance facilitates hematopoietic stem cell regeneration.

Authors:  Hu Wang; Hongna Zuo; Jin Liu; Fei Wen; Yawei Gao; Xudong Zhu; Bo Liu; Feng Xiao; Wengong Wang; Gang Huang; Bin Shen; Zhenyu Ju
Journal:  Cell Res       Date:  2018-08-27       Impact factor: 25.617

3.  N6-methyladenosine marks primary microRNAs for processing.

Authors:  Claudio R Alarcón; Hyeseung Lee; Hani Goodarzi; Nils Halberg; Sohail F Tavazoie
Journal:  Nature       Date:  2015-03-18       Impact factor: 49.962

4.  m(6)A RNA methylation promotes XIST-mediated transcriptional repression.

Authors:  Deepak P Patil; Chun-Kan Chen; Brian F Pickering; Amy Chow; Constanza Jackson; Mitchell Guttman; Samie R Jaffrey
Journal:  Nature       Date:  2016-09-07       Impact factor: 49.962

5.  N 6-methyladenosine of chromosome-associated regulatory RNA regulates chromatin state and transcription.

Authors:  Jun Liu; Xiaoyang Dou; Chuanyuan Chen; Chuan Chen; Chang Liu; Meng Michelle Xu; Siqi Zhao; Bin Shen; Yawei Gao; Dali Han; Chuan He
Journal:  Science       Date:  2020-01-16       Impact factor: 47.728

6.  Temporal Control of Mammalian Cortical Neurogenesis by m6A Methylation.

Authors:  Ki-Jun Yoon; Francisca Rojas Ringeling; Caroline Vissers; Fadi Jacob; Michael Pokrass; Dennisse Jimenez-Cyrus; Yijing Su; Nam-Shik Kim; Yunhua Zhu; Lily Zheng; Sunghan Kim; Xinyuan Wang; Louis C Doré; Peng Jin; Sergi Regot; Xiaoxi Zhuang; Stefan Canzar; Chuan He; Guo-Li Ming; Hongjun Song
Journal:  Cell       Date:  2017-09-28       Impact factor: 41.582

7.  eIF3 targets cell-proliferation messenger RNAs for translational activation or repression.

Authors:  Amy S Y Lee; Philip J Kranzusch; Jamie H D Cate
Journal:  Nature       Date:  2015-04-06       Impact factor: 49.962

8.  RNA m6A methylation regulates the ultraviolet-induced DNA damage response.

Authors:  Yang Xiang; Benoit Laurent; Chih-Hung Hsu; Sigrid Nachtergaele; Zhike Lu; Wanqiang Sheng; Chuanyun Xu; Hao Chen; Jian Ouyang; Siqing Wang; Dominic Ling; Pang-Hung Hsu; Lee Zou; Ashwini Jambhekar; Chuan He; Yang Shi
Journal:  Nature       Date:  2017-03-15       Impact factor: 49.962

9.  Transcription Impacts the Efficiency of mRNA Translation via Co-transcriptional N6-adenosine Methylation.

Authors:  Boris Slobodin; Ruiqi Han; Vittorio Calderone; Joachim A F Oude Vrielink; Fabricio Loayza-Puch; Ran Elkon; Reuven Agami
Journal:  Cell       Date:  2017-04-06       Impact factor: 41.582

10.  Monitoring Cell-Type-Specific Gene Expression Using Ribosome Profiling In Vivo During Cardiac Hemodynamic Stress.

Authors:  Shirin Doroudgar; Christoph Hofmann; Etienne Boileau; Brandon Malone; Eva Riechert; Agnieszka A Gorska; Tobias Jakobi; Clara Sandmann; Lonny Jürgensen; Vivien Kmietczyk; Ellen Malovrh; Jana Burghaus; Mandy Rettel; Frank Stein; Fereshteh Younesi; Ulrike A Friedrich; Victoria Mauz; Johannes Backs; Günter Kramer; Hugo A Katus; Christoph Dieterich; Mirko Völkers
Journal:  Circ Res       Date:  2019-07-09       Impact factor: 17.367

View more
  4 in total

1.  Emerging Role of Epitranscriptomics in Diabetes Mellitus and Its Complications.

Authors:  Xinqian Geng; Zheng Li; Ying Yang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-27       Impact factor: 6.055

Review 2.  Epitranscriptomics of cardiovascular diseases (Review).

Authors:  Stefanos Leptidis; Eleni Papakonstantinou; Kalliopi Io Diakou; Katerina Pierouli; Thanasis Mitsis; Konstantina Dragoumani; Flora Bacopoulou; Despina Sanoudou; George P Chrousos; Dimitrios Vlachakis
Journal:  Int J Mol Med       Date:  2021-11-18       Impact factor: 4.101

Review 3.  Role of epigenetic transgenerational inheritance in generational toxicology.

Authors:  Eric E Nilsson; Millissia Ben Maamar; Michael K Skinner
Journal:  Environ Epigenet       Date:  2022-02-16

Review 4.  Targeting Epigenetic Regulation of Cardiomyocytes through Development for Therapeutic Cardiac Regeneration after Heart Failure.

Authors:  Lindsay Kraus
Journal:  Int J Mol Sci       Date:  2022-10-06       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.